Skip to main content

Carlos Molina Cateriano

Institutions of which they are part

Head of group
Stroke research
Vall Hebron Institut de Recerca

Carlos Molina Cateriano

Institutions of which they are part

Head of group
Stroke research
Vall Hebron Institut de Recerca

Projects

INVICTUS

IP: Joan Montaner Villalonga
Collaborators: Marta Aurora Rubiera Del Fueyo, Jorge Pagola Pérez Blanca, Bustamante Rangel, Alejandro, José Alvarez Sabin, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Yolanda Riba Llena, Marc Ribó Jacobi, Maria Pilar Delgado Martínez, Carlos Molina Cateriano, Anna Rosell Novel, David Rodriguez Luna, Mª Ángeles Muchada López, Estevo Santamarina Pérez
Funding agency: Instituto de Salud Carlos III
Funding: 247695.66
Reference: RD12/0014/0005
Duration: 01/01/2013 - 31/03/2017

Malalties neurovasculars

IP: Carlos Molina Cateriano
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding: 30000
Reference: INT12/295
Duration: 01/01/2013 - 31/12/2013

Impacto de la evaluación neurovascular y determinación de biomarcadores en el diagnóstico pre-hospitalario del ictus hiperagudo

IP: Carlos Molina Cateriano
Collaborators: Marta Aurora Rubiera Del Fueyo, Jorge Pagola Pérez Blanca, Anna Penalba Morenilla, Maria Pilar Meler Amella
Funding agency: Instituto de Salud Carlos III
Funding: 108075.99
Reference: PI11/01677
Duration: 01/01/2012 - 31/12/2014

European Stroke Research Network for Hypothermia (EUROHYP-1) Grant Agreement nº 278709

IP: Carlos Molina Cateriano
Collaborators: Marta Aurora Rubiera Del Fueyo, Jorge Pagola Pérez Blanca, Estela Sanjuan Menendez, Marc Ribó Jacobi, Maria Pilar Meler Amella, David Rodriguez Luna, Mª Ángeles Muchada López
Funding agency: EUROPEAN COMMISSION
Funding: 655474
Reference: 'EUROHYP-1_FP7HEALTH2011
Duration: 01/02/2012 - 31/07/2018

Related news

The Consortium will create a platform to facilitate a personalised management for stroke patients, enabling a more efficient personalized monitoring and patient follow up.

Funding is key to bringing the neuroprotective drug ApTOLL to market and providing a new therapeutic option for the patients.

The award is a recognition for his significant contribution to the development of research in multiple sclerosis within the Catalan Institute of Health.

Related professionals

Palomar Muñoz, Azahara Maria

Palomar Muñoz, Azahara Maria

Senior researcher
Molecular Medical Imaging
Read more
Boto Ruiz, Neus

Boto Ruiz, Neus

Transfusional Medicine
Read more
Inés Carolina Balón  Llerena

Inés Carolina Balón Llerena

Administration and Management
Molecular Medical Imaging
Read more
Falcó Roget, Anna

Falcó Roget, Anna

Research technician
Infectious Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.